Mr Luis Angel Roa Cordero, NP-C | |
Islote Ii Casa 196, Arecibo, PR 00612 | |
(787) 320-6268 | |
Not Available |
Full Name | Mr Luis Angel Roa Cordero |
---|---|
Gender | Male |
Speciality | Nurse Practitioner - Family |
Location | Islote Ii Casa 196, Arecibo, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598340929 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 3799 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Luis Angel Roa Cordero, NP-C Islote Ii Casa 196, Arecibo, PR 00612 Ph: (787) 320-6268 | Mr Luis Angel Roa Cordero, NP-C Islote Ii Casa 196, Arecibo, PR 00612 Ph: (787) 320-6268 |
News Archive
"The neglected tropical diseases (NTDs) produce a devastating level of chronic disability in sub-Saharan Africa, with some estimates suggesting that the NTD disease burden exceeds tuberculosis and is one-half that of malaria," Julie Noblick and Richard Skolnick of George Washington University and Peter Hotez of the Sabin Vaccine Institute write in a PLoS Neglected Tropical Diseases editorial.
A panel of advisors to the United States Food and Drug Administration (FDA) has voted unanimously in favor of an experimental gene therapy to treat patients with a rare kind of hereditary blindness.
The considerable progress in recent years-;including the 22-fold increase in the number of people receiving anti-retroviral drugs between 2001-2010-;has been due to scientific breakthroughs and to civil society's efforts to keep AIDS on the political agenda. This is now changing.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
› Verified 1 days ago